Dinaciclib (SCH 727965)

Catalog No. A11129

Dinaciclib (SCH 727965)是一种有效且选择性的细胞周期蛋白依赖性激酶(CDK)抑制剂,选择性抑制CDK1,CDK2,CDK5和CDK9,IC50值分别为3、1、1和4 nM。
  • Sepideh Izadi, .et al. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression, Pharm Res, 2020, Sep 17;37(10):196 PMID: 32944844
  • Shahin Hallaj, .et al. Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib, Life Sci, 2020, Jul 26 PMID: 32726663
  • Washio I, .et al. Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines, Drug Metab Dispos, 2018, Mar;46(3):214-222 PMID: 29246888
Catalog Num A11129
M. Wt 396.5
Formula C21H28N6O2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 779353-01-4
Synonyms SCH727965, SCH-727965
SMILES CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO
Dinaciclib (SCH 727965)是一种有效且选择性的细胞周期蛋白依赖性激酶(CDK)抑制剂,选择性抑制CDK1,CDK2,CDK5和CDK9,IC50值分别为3、1、1和4 nM。
Targets
CDK2 (Cell-free assay) CDK5 (Cell-free assay) CDK1 (Cell-free assay) CDK9 (Cell-free assay)
1 nM1 nM3 nM4 nM
In vitro (25°C) DMSO Warmed: 22 mg/mL (55.48 mM)
Water Insoluble
Ethanol Warmed: 7 mg/mL (17.65 mM)
In vivo 2% DMSO+30% PEG 300+ddH2O 9 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 25.22 mL 126.1 mL 252.21 mL
0.5 mM 5.04 mL 25.22 mL 50.44 mL
1 mM 2.52 mL 12.61 mL 25.22 mL
5 mM 0.5 mL 2.52 mL 5.04 mL

*The above data is based on the productmolecular weight 396.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.